Morgan E T
Department of Pharmacology, Emory University, Atlanta, GA 30322.
Biochem Pharmacol. 1991 Jun 21;42(1):51-7. doi: 10.1016/0006-2952(91)90680-4.
Interferons and interferon inducers cause a reduction in hepatic microsomal cytochrome P450 [AH, reduced-flavoprotein: oxygen oxidoreductase (RH hydroxylating), EC 1.14.14.1] content and drug-metabolizing activities in experimental animals. In the present study, the acute effects of administration of the interferon inducer polyriboinosinic acid.polyribocytidylic acid (poly rI.poly rC) to female rats on expression of the microsomal apoprotein and hepatic mRNA for P450IIC12, a constitutive enzyme comprising a significant fraction of the total P450 in untreated female rats, were examined. Poly rI.poly rC treatment (10 mg/kg, i.p.) caused a suppression of P450IIC12 apoprotein that was of greatest magnitude (47% of control levels) 24 hr after injection. P450IIC12 was still suppressed significantly (P less than 0.05) 48 hr after treatment. The time courses of suppression and recovery of P450IIC12 protein, as well as the magnitude of the effect, were similar to those of total microsomal P450 measured spectrophotometrically. P450IIC12 mRNA levels were also suppressed by the poly rI.poly rC treatment, reaching 29% of control values within 24 hr. Comparison of the kinetics of suppression of the P450IIC12 mRNA and apoprotein indicated that at least part of the suppression of the protein is mediated pretranslationally. However, the existence of a posttranslational component could not be excluded. Concomitant with the suppression of P450IIC12, actin mRNA content was found to be elevated by at least 3.6-fold in the livers of poly rI.poly rC-treated female rats, with the maximum effect occurring 12 hr after injection of the drug. This effect of poly rI.poly rC on expression of actin mRNA appeared to be at least partially sex-specific, since in a previous study [Morgan ET and Norman CA, Drug Metab Dispos 18: 649-653, 1990] a significant effect of the interferon inducer on actin expression was not observed in livers of male rats.
干扰素和干扰素诱导剂可使实验动物肝微粒体细胞色素P450[AH,还原黄素蛋白:氧氧化还原酶(RH羟化),EC 1.14.14.1]含量及药物代谢活性降低。在本研究中,检测了给雌性大鼠注射干扰素诱导剂聚肌苷酸-聚胞苷酸(poly rI.poly rC)后,对微粒体载脂蛋白表达以及P450IIC12肝mRNA表达的急性影响,P450IIC12是一种组成型酶,在未处理的雌性大鼠总P450中占很大比例。聚肌苷酸-聚胞苷酸处理(10mg/kg,腹腔注射)导致P450IIC12载脂蛋白受到抑制,在注射后24小时抑制程度最大(为对照水平的47%)。处理后48小时,P450IIC12仍受到显著抑制(P<0.05)。P450IIC12蛋白抑制和恢复的时间进程以及作用程度,与通过分光光度法测定的总微粒体细胞色素P450相似。聚肌苷酸-聚胞苷酸处理也使P450IIC12 mRNA水平受到抑制,在24小时内降至对照值的29%。对P450IIC12 mRNA和载脂蛋白抑制动力学的比较表明,至少部分蛋白质抑制是在翻译前介导的。然而,不能排除存在翻译后成分。与P450IIC12受到抑制同时,发现聚肌苷酸-聚胞苷酸处理的雌性大鼠肝脏中肌动蛋白mRNA含量升高至少3.6倍,在注射药物后12小时出现最大效应。聚肌苷酸-聚胞苷酸对肌动蛋白mRNA表达的这种作用似乎至少部分具有性别特异性,因为在先前的一项研究中[Morgan ET和Norman CA,药物代谢与处置18:649 - 653,1990],未在雄性大鼠肝脏中观察到干扰素诱导剂对肌动蛋白表达有显著影响。